🔎 Trials Near Me

Home › Degenerasyon ng Macula › Georgia

Pag-aaral pangklinika para sa Degenerasyon ng Macula sa Georgia

6 pag-aaral para sa Degenerasyon ng Macula ang naghahanap ng mga kalahok sa mga site sa Georgia.

Mga Lungsod sa Georgia

Opisyal na teksto ng pag-aaral (English)

A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy

  • Southeast Retina Center, Augusta
  • Georgia Retina - Marietta, Marietta
Nagre-recruitPhase 3
Edad 50 hanggang 85 · Lahat ng kasarian · Na-update Nob 5, 2026 · NCT06541704

A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

  • Georgia Retina, Marietta
  • Marietta Eye Clinic, Marietta
Nagre-recruitPhase 2/3
Edad 60 pataas · Lahat ng kasarian · Na-update Nob 3, 2026 · NCT06635148

Age-Related Macular Degeneration Benchmark Imaging Dataset (ABID)

  • Emory University, Atlanta
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 50 pataas · Lahat ng kasarian · Na-update Okt 30, 2026 · NCT06924021

A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration

  • Emory University Eye Center, Atlanta
Nagre-recruitPhase 1
Edad 50 pataas · Lahat ng kasarian · Na-update Set 3, 2026 · NCT03178149

Active AMD Study to Improve Function in Veterans

  • Atlanta VA Medical and Rehab Center, Decatur, GA, Decatur
Nagre-recruit
Edad 65 hanggang 89 · Lahat ng kasarian · Na-update Peb 23, 2026 · NCT05932069

Study to Evaluate the Safety of CG-P5 Peptide Eye Drops in Patients Diagnosed With Age-related Wet Macular Degeneration

  • CBCC Global Research Site:001, Augusta
Nagre-recruitPhase 1
Edad 50 pataas · Lahat ng kasarian · Na-update Peb 7, 2025 · NCT06132035

Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.